Hallmarks of triple negative breast cancer emerging at last?

被引：38

作者：

Bernardi, Rosa ^{[1
]}

Gianni, Luca ^{[2
]}

机构：

[1] Ist Sci San Raffaele, Div Mol Oncol, I-20132 Milan, Italy

[2] Hosp San Raffaele, Dept Med Oncol, I-20132 Milan, Italy

来源：

CELL RESEARCH | 2014年 / 24卷 / 08期

关键词：

D O I：

10.1038/cr.2014.61

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

Triple negative breast cancers (TNBC) are clinically heterogeneous but mostly aggressive malignancies devoid of expression of the estrogen, progesterone and HER2 (ERBB2 or NEU) receptors. Recent evidence shows that basal endoplasmic reticulum stress (ERS) is typically activated in TNBC and cooperates with hypoxia signaling to promote tumor progression and relapse; ERS and hypoxia response may therefore be among the long-searched hallmarks of TNBC.

引用

页码：904 / 905

页数：2

共 50 条

[41] Advancements in clinical research and emerging therapies for triple-negative breast cancer treatment
Xu, Lili
Xu, Pengtao
Wang, Jingsong
Ji, Hui
Zhang, Lin
Tang, Zhihua
EUROPEAN JOURNAL OF PHARMACOLOGY, 2025, 988
[42] Targeting replication stress in triple negative breast cancer treatment regimen: An emerging approach
Rajamanickam, Subapriya
Park, Jun Hyoung
Bates, Kaitlyn
Timilsina, Santosh
Eedunuri, Vijay Kumar
Onyeagucha, Benjamin
Subbarayalu, Panneerdoss
Abdelfattah, Nourhan
Jung, Kwang Hwa
Favours, Edward
Mohammad, Tabrez A.
Chen, Hung-I Harry
Vadlamudi, Ratna K.
Chen, Yidong
Kaipparettu, Benny A.
Arbiser, Jack L.
Rao, Manjeet K.
CANCER RESEARCH, 2018, 78 (04)
[43] Evaluation of New Emerging Markers to Detect Triple Negative Breast Cancer in Fluid Cytology
Khedr, Maha
Young, Alecia
Beshai, Boulos
Pokharel, Saraswati
Khoury, Thaer
Morrison, Carl
Yang, Zhongbo
LABORATORY INVESTIGATION, 2024, 104 (03) : S433 - S434
[44] Current Treatment Landscape and Emerging Therapies for Metastatic Triple-Negative Breast Cancer
Adel, Nelly G.
AMERICAN JOURNAL OF MANAGED CARE, 2021, 27 (05): : S87 - S96
[45] Triple-Negative Breast Cancer: Emerging Biomarkers for Early Diagnosis, Prognosis, and Treatment
Roshanizadeh, Zahra
Haghshenas, Mohammad Reza
Ghaderi, Abbas
MIDDLE EAST JOURNAL OF CANCER, 2024, 15 (04) : 257 - 271
[46] The emerging role of immune checkpoint inhibitors in the treatment of triple-negative breast cancer
Singh, Sima
Numan, Arshid
Maddiboyina, Balaji
Arora, Saahil
Riadi, Yassine
Md, Shadab
Alhakamy, Nabil A.
Kesharwani, Prashant
DRUG DISCOVERY TODAY, 2021, 26 (07) : 1721 - 1727
[47] Triple-Negative Breast Cancer
Winkeljohn, Debra L.
CLINICAL JOURNAL OF ONCOLOGY NURSING, 2008, 12 (06) : 861 - 863
[48] Triple-Negative Breast Cancer
Hudis, Clifford A.
CANCER JOURNAL, 2010, 16 (01): : 10 - 11
[49] Pathology of triple negative breast cancer
Borri, Filippo
Granaglia, Annarita
SEMINARS IN CANCER BIOLOGY, 2021, 72 : 136 - 145
[50] MicroRNAs and Triple Negative Breast Cancer
D'Ippolito, Elvira
Iorio, Marilena V.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2013, 14 (11): : 22202 - 22220

← 1 2 3 4 5 →